Fisher and Paykel Healthcare drives NZ stocks to weaker finish

Fisher and Paykel Healthcare drives NZ stocks to weaker finish
Fisher and Paykel fell on news that the US Food and Drug Administration has granted a “fast track” designation for competitor Nasdaq-listed Incannex’s fixed-dose product for the treatment of obstructive sleep apnea. (Image: Supplied)
Jamie Gray
Falls in some leading stocks helped mask a positive tone for others, leaving the New Zealand sharemarket lower on the day.The S&P/NZX 50 Index closed down 31.63 points, or 0.23%, to 13,483.99, with 41.3 million shares worth $155m trading.There were 66 gains and 74 falls on the main board.Fisher and Paykel Healthcare (FPH), the market’s biggest stock with a 16% weighting on the S&P/NZX 50 index, dropped 26c to $37.94 but was off its lows for the day and the week.US competitionSalt Funds managing director Matt Goodson said FPH had f...

More Markets

Ousted Rakon director could pocket takeover windfall
Markets

Ousted Rakon director could pocket takeover windfall

Jon Raby couldn't get elected to the Rakon board but snapped up some shares anyway.

Why Rakon’s $390m takeover failed
Markets Best of BusinessDesk

Why Rakon’s $390m takeover failed

The Skyworks deal collapsed in 2024. Now, another deal is on the table.

Brokers reveal top NZX picks for 2026
Markets

Brokers reveal top NZX picks for 2026

Billions shifting from term deposits could boost NZX heavyweights and recovery plays.

Business confidence boost uninspired NZ sharemarket
Markets Market Close

Business confidence boost uninspired NZ sharemarket

The S&P/NZX 50 Index closed at 13,656.05, down 27.24 points or 0.2%.

Graham Skellern 13 Jan 2026